Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg
Clinical trial NCT02742324 · COMPLETED
Trial details
- NCT number
- NCT02742324
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2021-12-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.